aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded through the merger of INC Research and inVentiv Health, Syneos Health® is a unique, fully integrated contract research organization (CRO) that provides end-to-end clinical and commercial solutions. The company's core mission is to accelerate the delivery of biopharmaceutical therapies to market, improving patient outcomes globally. Syneos Health offers a comprehensive range of services, including clinical development, bioanalytical services, and commercialization strategies, focusing on the biopharmaceutical and healthcare sectors.
Notable affiliated individuals include industry leaders from both legacy companies, contributing extensive expertise in clinical trials and commercial strategies. Syneos Health has garnered significant investment from prominent venture capital firms and institutional investors. Key achievements include successful partnerships with leading biopharmaceutical companies and a robust portfolio of completed clinical trials. The overall impact of Syneos Health is evident in its ability to streamline the drug development process, ultimately enhancing the availability of innovative therapies for patients worldwide.
Operating Status
Active
Ownership Type(s)
Public, Private Equity
Main Product(s)
Drug Development, Clinical Trials
Technology
Analytics
Tags
Biotech, Healthtech
Model Types
Professional Services
Revenue Type(s)
Consulting
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Syneos Health founded?
Syneos Health was founded in 1998.
Where is Syneos Health’s headquarters located?
Syneos Health’s headquarters is located in Burlington, MA, US.
When was Syneos Health’s last funding round?
Syneos Health’s most recent funding round was for $524.6M (USD) in March 2021.
How many employees does Syneos Health have?
Syneos Health has 29395 employees as of Feb 5, 2024.
How much has Syneos Health raised to-date?
As of July 05, 2023, Syneos Health has raised a total of $999.6M (USD) since Mar 1, 2021.
Add Comparison
Total Raised to Date
$999.6M
USD
Last Update Mar 1, 2021
Last Deal Details
$524.6M
USD
Mar 1, 2021
Post Ipo Secondary
Total Employees Over Time
29395
As of Feb 2024
Syneos Health Address
One Van De Graaff Drive
Burlington,
Massachusetts
02420
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts